We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTMO
11876
CALL
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$93K ﹤0.01%
3,133
-1,240
-28% -$41.3K
CGEN icon
11877
Compugen
CGEN
$246M
$92K ﹤0.01%
28,645
-292,375
-91% -$987K
CPIX icon
11878
CALL
Cumberland Pharmaceuticals
CPIX
$127M
$92K ﹤0.01%
+32,800
New +$109K
CRBP icon
11879
PUT
Corbus Pharmaceuticals
CRBP
$211M
$92K ﹤0.01%
5,807
-4,616
-44% -$61.2K
ETON icon
11880
PUT
Eton Pharmaceutcials
ETON
$1.71B
$92K ﹤0.01%
21,200
-800
-4% -$3.15K
RKTO
11881
Rocket One Inc
RKTO
$17.7M
$92K ﹤0.01%
5,336
+4,883
+1,078% +$81.7K
NMG
11882
CALL
Nouveau Monde Graphite
NMG
$474M
$92K ﹤0.01%
+13,300
New +$94.6K
PHX
11883
CALL
DELISTED
PHX Minerals
PHX
$92K ﹤0.01%
+30,200
New +$76.9K
INFI
11884
PUT
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$92K ﹤0.01%
80,900
-132,400
-62% -$158K
BNED icon
11885
CALL
Barnes & Noble Education
BNED
$415M
$91K ﹤0.01%
255
-2,506
-91% -$1.34M
CYCN icon
11886
CALL
Cyclerion Therapeutics
CYCN
$17.7M
$91K ﹤0.01%
4,100
-185
-4% -$4.46K
SANW
11887
DELISTED
S&W Seed Co
SANW
$91K ﹤0.01%
+2,259
New +$99K
VRNA
11888
DELISTED
Verona Pharma
VRNA
$91K ﹤0.01%
18,333
-12,447
-40% -$72.4K
ASMB icon
11889
Assembly Biosciences
ASMB
$694M
$90K ﹤0.01%
3,631
-1,119
-24% -$24K
EZPW icon
11890
Ezcorp Inc
EZPW
$2.03B
$90K ﹤0.01%
14,923
-52,608
-78% -$328K
GDXD icon
11891
MicroSectors Gold Miners -3x Inverse Leveraged ETN
GDXD
$434M
$90K ﹤0.01%
5
GPUS
11892
CALL
Hyperscale Data Inc
GPUS
$28.3M
0
NPKI
11893
CALL
NPK International
NPKI
$1.12B
$90K ﹤0.01%
+24,600
New +$91.4K
CMRX
11894
PUT
DELISTED
Chimerix, Inc.
CMRX
$90K ﹤0.01%
19,600
-49,000
-71% -$273K
BSQR
11895
CALL
DELISTED
BSQUARE Corporation
BSQR
$90K ﹤0.01%
52,000
-3,200
-6% -$5.25K
CALC icon
11896
CALL
CalciMedica
CALC
$3.17M
$89K ﹤0.01%
5,150
-2,393
-32% -$45.6K
DOGZ icon
11897
PUT
Dogness International Corp
DOGZ
$18.1M
$89K ﹤0.01%
+740
New +$59.5K
OCG icon
11898
Oriental Culture Holding
OCG
$3.12M
$89K ﹤0.01%
6
-4
-40% -$61K
RIGL icon
11899
PUT
Rigel Pharmaceuticals
RIGL
$868M
$89K ﹤0.01%
2,980
-6,530
-69% -$177K
IVAC
11900
DELISTED
Intevac Inc
IVAC
$89K ﹤0.01%
16,574
-26,112
-61% -$138K

Similar funds

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.